| Toxicological requirements for sclerosing agents or other chemicals for female sterilization. | |
| | |
MedLine Citation:
|
PMID: 8904514 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
There are no guidelines regulating the technologies available for Fallopian tube occlusion. Generally accepted regulatory requirements cannot be applied directly to the safety assessment of these technologies. The more appropriate guidelines are those regulating medical devices. Each method has to be evaluated on its own merits taking into consideration the duration of contact with tissue and the chemical and physical composition of the occlusive agents. |
| | |
Authors:
|
R Heywood |
Related Documents
:
|
15185624 - Disruptive technology: new medical advances are troublesome for even the most successfu... 11187614 - The french virtual medical university. 12386664 - Hand-held computers in healthcare: what software programs are available? 20697074 - Technology evolution: is it survival of the fittest? 1109414 - The paucity of course work in medical care evaluation. 16020214 - Dermal fillers: complications and informed consent. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Volume: 51 Suppl 1 ISSN: 0020-7292 ISO Abbreviation: Int J Gynaecol Obstet Publication Date: 1995 Dec |
Date Detail:
|
Created Date: 1997-02-20 Completed Date: 1997-02-20 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 0210174 Medline TA: Int J Gynaecol Obstet Country: IRELAND |
Other Details:
|
Languages: eng Pagination: S41-5 Citation Subset: IM |
Affiliation:
|
St. George's House, Huntingdon, Cambridge, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Evaluation, Preclinical Female Humans Sclerosing Solutions / adverse effects, therapeutic use* Sterilization, Tubal / adverse effects, methods* |
| Chemical | |
Reg. No./Substance:
|
0/Sclerosing Solutions |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: New methods for transcervical cannulation of the fallopian tube.
Next Document: Quinacrine: sclerosing agent of the utero-tubal junction in women, with anticarcinogenic actions in ...